In addition, childhood cancer survivors who received higher doses of cranial radiation therapy to kill the cancer showed even greater risk of stroke in later life, according to the study, which appears in today’s issue of the Journal of Clinical Oncology and is available online.
“This is important because leukemia and brain tumors are the two most common types of childhood cancer, representing more than half of childhood cancers,” said Dr. Daniel Bowers, associate professor of pediatrics and lead author of the study.
Other studies have shown that survivors of childhood leukemia or brain cancer are also at higher risk for cardiac dysfunction, obesity, short stature, and hormone and neurocognitive deficits. This is the first study to examine the risk to survivors for late-occurring strokes, which occur at least five years after their cancer diagnosis.
Leukemia and brain tumors account for 53 percent of all cancers among children younger than 15 years of age and are annually diagnosed in more than 4,400 U.S. children. Most patients live at least five years beyond their diagnosis to become long-term cancer survivors — 79 percent for leukemia and 73 percent for brain tumors.
The peak incidence for both leukemia and brain tumors is during vulnerable neurocognitive development, so researchers suspect that the radiation therapy typically received at such a crucial time may influence the later risk for stroke.
Among the study’s findings:
- Compared with siblings, leukemia survivors were two to three times more likely to suffer a stroke.- Brain-cancer survivors were eight to 10 times more likely to suffer a stroke.
- Patients with a history of relapse of their cancer were at a greater risk for stroke, likely a result of increased radiation treatment, the researchers concluded.
The effects of late-occurring strokes, which can be life-threatening or result in permanent or severe disability, can be particularly devastating in these cases because they often hit when the childhood cancer survivors are reaching early adulthood – in their late 20s and early 30s.
“Many people think, ‘You’re five years out from your cancer, you must be cured, and you can get on with the rest of your life.’ But these patients suddenly develop a new complication of the cancer and its treatments,” Dr. Bowers said.
UT Southwestern is one of 26 sites participating in the Childhood Cancer Survivors Study on long-term side effects for cancer survivors. Children’s Medical Center Dallas is also a member and contributed patients to the study. The study established a database of information on some 14,000 patients who survived at least five years after being diagnosed with cancer during childhood. The national database includes about 4,000 leukemia survivors and about 1,700 survivors of brain tumors.
Dr. Bowers has been culling through the data involving strokes, and previously discovered a greater stroke risk for survivors of Hodgkin disease.
Brain tumors and leukemia might seem like apples and oranges because leukemia is a bone-marrow cancer and brain cancers are by definition tumors in the brain.
“But they are similar in important ways,” Dr. Bowers noted. “They both are most likely to occur in young childhood, and both groups also get targeted radiation therapy to the brain.”
The current treatment regiments for brain tumors and leukemia are aimed at reducing the use of radiation therapy, a move designed to lessen learning problems associated with radiation therapy.
“It would be interesting to see whether it may also impact the occurrence of strokes,” Dr. Bowers said.
Researchers are now formulating a follow-up study to identify a way of screening patients who might be at risk of having strokes, with the goal of eventually developing a preventive strategy.
Other researchers involved in the study were senior author Dr. Kevin Oeffinger, a former faculty member at UT Southwestern, now with Memorial Sloan-Kettering Cancer Center, as well as researchers from UT M.D. Anderson Cancer Center, the Food and Drug Administration, the Fred Hutchinson Cancer Research Center, the University of Michigan, St. Jude Children’s Research Hospital, and the Children’s National Medical Center.
Russell Rian | EurekAlert!
Study tracks inner workings of the brain with new biosensor
16.08.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn
Foods of the future
15.08.2018 | Georg-August-Universität Göttingen
New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference
Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...
Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...
Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.
When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...
Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.
Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....
Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.
Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...
17.08.2018 | Event News
08.08.2018 | Event News
27.07.2018 | Event News
17.08.2018 | Physics and Astronomy
17.08.2018 | Information Technology
17.08.2018 | Life Sciences